MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

A case of GAD ataxia and stiff leg syndrome

S. Kalampokini, A. Artemiadis, P. Zis, P. Bargiotas, G. Hadjigeorgiou (Nicosia, Cyprus)

Meeting: MDS Virtual Congress 2021

Abstract Number: 35

Keywords: Ataxia: Clinical features, Ataxia: Etiology and Pathogenesis

Category: Ataxia

Objective: Stiff person syndrome and cerebellar ataxia are immunological neurological syndromes associated with the presence of glutamic acid decarboxylase (GAD) antibodies.

Background: Patients with GAD associated cerebellar ataxia present with a progressive subacute or chronic cerebellar syndrome, which may be combined with other manifestations such as stiffness, oculomotor dysfunction, epilepsy and cognitive dysfunction. Other autoimmune disorders can be observed in patients with GAD ataxia such as diabetes mellitus or thyroiditis, while an underlying neoplasia has been reported in about 12% of the patients.

Method: We present a case of a 42-year-old woman, who presented with gait difficulty of subacute onset, dysarthria, double vision and painful spasms of the lower extremities. Family history was negative for ataxia or other movement disorders. Neurological examination revealed horizontal nystagmus, dysarthria, ataxia of the left upper and lower extremity and leg stiffness.

Results: Brain magnetic resonance imaging (MRI) excluded a structural lesion and cerebrovascular fluid (CSF) analysis excluded an inflammatory cause for her symptoms. The patient had high serum and CSF GAD antibodies (serum >12.000 IU/ml, CSF >120 IU/ml). Amphiphysin antibodies were negative in the CSF and a paraneoplasmatic origin could be excluded through computer tomography of the thorax, abdomen, mammography and colonoscopy. The patient was treated with 1 gr methylprednisolone intravenous daily for 5 days followed by 60mg/day oral methylprednisolone. She also received gabapentin 900 mg/d. At 3-month-follow-up she had a moderate improvement of ataxia and nystagmus, while immunotherapy with mycophenolate mofetil was started at that point.

Conclusion: GAD ataxia and stiff leg syndrome are rare neurological disorders, with a few other cases with both conditions reported in the literature. They can be adequately managed using steroids, intravenous immunoglobulin or other second line treatment such as azathioprine, rituximab and mycophenolate mofetil. Therefore, clinicians and movement disorders specialists should include them in the differential diagnosis of ataxia, especially in cases with negative family history.

To cite this abstract in AMA style:

S. Kalampokini, A. Artemiadis, P. Zis, P. Bargiotas, G. Hadjigeorgiou. A case of GAD ataxia and stiff leg syndrome [abstract]. Mov Disord. 2021; 36 (suppl 1). https://www.mdsabstracts.org/abstract/a-case-of-gad-ataxia-and-stiff-leg-syndrome/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to MDS Virtual Congress 2021

MDS Abstracts - https://www.mdsabstracts.org/abstract/a-case-of-gad-ataxia-and-stiff-leg-syndrome/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley